3871 - 3880 of 9104 Results
Title
Year
-
OPENTitle: Addressing the Challenges of Translating LRRK2 Biology into Disease‐Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange InitiativeJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70397Best OA location URL: https://doi.org/10.1002/mds.70397Citation Count: 0
- [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteers2019OPENTitle: [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteersJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 46Issue #: 10Start Page: 2051End Page: 2064Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00259-019-04369-6Citation Count: 83
- Insights into the Influence of Specific Splicing Events on the Structural Organization of LRRK22018OPENTitle: Insights into the Influence of Specific Splicing Events on the Structural Organization of LRRK2Journal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 19Issue #: 9Start Page: 2784End Page: 2784Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms19092784Best OA location URL: https://www.mdpi.com/1422-0067/19/9/2784/pdf?version=1537093660Citation Count: 2
-
OPENTitle: Dopamine Receptor D3 Expression Is Altered in CD4+ T-Cells From Parkinson's Disease Patients and Its Pharmacologic Inhibition Attenuates the Motor Impairment in a Mouse ModelJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page: 981End Page: 981Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2019.00981Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2019.00981/pdfCitation Count: 60
-
OPENTitle: L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehiclesJournal Name: Nanomedicine: Nanotechnology, Biology and MedicinePublisher: Elsevier BVVol: 15Issue #: 1Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nano.2018.08.011Best OA location URL: http://hdl.handle.net/10044/1/63483Citation Count: 100
- Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patients2017RESTRICTEDTitle: Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1423End Page: 1431Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27136Citation Count: 176
-
OPENTitle: Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine‐Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme‐Linked Immunosorbent Assay–Based MethodJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2095End Page: 2100Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28175Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28175Citation Count: 33
- Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism2020OPENTitle: Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 72Issue #:Start Page: 75End Page: 79Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.02.003Best OA location URL: http://hdl.handle.net/11577/3350481Citation Count: 21
-
OPENTitle: Synapsin III is a key component of α‐synuclein fibrils in Lewy bodies of PD brainsJournal Name: Brain PathologyPublisher: WileyVol: 28Issue #: 6Start Page: 875End Page: 888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bpa.12587Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8028549Citation Count: 51
-
OPENTitle: Identification and in vitro characterization of C05-01, a PBB3 derivative with improved affinity for alpha-synucleinJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1749Issue #:Start Page: 147131End Page: 147131Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.brainres.2020.147131Best OA location URL: https://doi.org/10.1016/j.brainres.2020.147131Citation Count: 32